| 000 | 01541 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517055642.0 | ||
| 264 | 0 | _c20160608 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1742-4658 | ||
| 024 | 7 |
_a10.1111/febs.13557 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNovakova, Zora | |
| 245 | 0 | 0 |
_aDesign of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities. _h[electronic resource] |
| 260 |
_bThe FEBS journal _cJan 2016 |
||
| 300 |
_a130-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmides _xchemical synthesis |
| 650 | 0 | 4 |
_aAntigens, Surface _xmetabolism |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aGlutamate Carboxypeptidase II _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen Bonding |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPhosphoric Acids _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aCerny, Jiri | |
| 700 | 1 | _aChoy, Cindy J | |
| 700 | 1 | _aNedrow, Jessie R | |
| 700 | 1 | _aChoi, Joeseph K | |
| 700 | 1 | _aLubkowski, Jacek | |
| 700 | 1 | _aBerkman, Clifford E | |
| 700 | 1 | _aBarinka, Cyril | |
| 773 | 0 |
_tThe FEBS journal _gvol. 283 _gno. 1 _gp. 130-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/febs.13557 _zAvailable from publisher's website |
| 999 |
_c25347940 _d25347940 |
||